Management of sickle cell disease: current practices and challenges in a northeastern region of the Democratic Republic of the Congo

References

• Piel FB, Patil AP, Howes RE, et al. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet. 2013;38(9861):142–151. DOI:https://doi.org/10.1016/S0140-6736(12)61229-X.
   Google Scholar
• Tshilolo L, Tomlinson G, Williams TN, et al. Hydroxyurea for children with sickle cell anemia in Sub-Saharan Africa. N Engl J Med. 2019;380(2):121–131. DOI:https://doi.org/10.1056/NEJMoa1813598.
   PubMed Web of Science ®Google Scholar
• Aygun B, Odame I. A global perspective on sickle cell disease. Pediatr Blood Cancer. 2012;59(2):386–390. DOI:https://doi.org/10.1002/pbc.24175.
   PubMed Web of Science ®Google Scholar
• Mulumba LL, Wilson L. Sickle cell disease among children in Africa: An integrative literature review and global recommendations. Int J Afr Nurs Sci. 2015;3:56–64. DOI:https://doi.org/10.1016/J.IJANS.2015.08.002.
   Google Scholar
• WHO, Africa Regional Committee. Sickle-cell anaemia: a strategy for the who African region. Report of the Sixtieth Session Malabo, Equatorial Guinea, 30 August – 3 September 2010AFR/RC60/8 [cited 2020 May 17]. Available from: https://apps.who.int/iris/handle/10665/1682.
   Google Scholar
• Wailoo K. Sickle cell disease – a history of Progress and Peril. N Engl J Med. 2017;376(9):805–807. DOI:https://doi.org/10.1056/NEJMp1700101.
   PubMed Web of Science ®Google Scholar
• Rahimy MC, Gangbo A, Ahouignan G, et al. Newborn screening for sickle cell disease in the Republic of Benin. J Clin Pathol. 2009;62(1):46–48. DOI:https://doi.org/10.1136/jcp.2008.059113.
   PubMed Web of Science ®Google Scholar
• De Montalembert M, Tshilolo L. Is therapeutic progress in the management of sickle cell disease applicable in sub-Saharan Africa? Med Trop. 2007;67(6):612–616.
   PubMedGoogle Scholar
• Allali S, Chalumeau M, Launay O, et al. Conjugate Haemophilus influenzae type b vaccines for sickle cell disease. Cochrane Database Syst Rev. 2018;8(8):CD011199. DOI:https://doi.org/10.1002/14651858.CD011199.
   PubMedGoogle Scholar
• Tonen-Wolyec S, Batina-Agasa S, Muwonga J, et al. Acceptability, feasibility, and individual preferences of blood-based HIV self-testing in a population-based sample of adolescents in Kisangani, Democratic Republic of the Congo. PLoS One. 2019;14(7):e0218795. DOI:https://doi.org/10.1371/journal.pone.0218795.
   PubMed Web of Science ®Google Scholar
• Agasa B, Bosunga K, Opara A, et al. Prevalence of sickle cell disease in a northeastern region of the Democratic Republic of Congo: what impact on transfusion policy? Transfus Med. 2010;20(1):62–65. DOI:https://doi.org/10.1111/j.1365-3148.2009.00943.x.
   PubMed Web of Science ®Google Scholar
• Boemer F, Cornet Y, Libioulle C, et al. 3-years experience review of neonatal screening for hemoglobin disorders using tandem mass spectrometry. Clin Chim Acta. 2011;412(15-16):1476–1479. DOI:https://doi.org/10.1016/j.cca.2011.04.031.
   PubMed Web of Science ®Google Scholar
• Boemer F, Ketelslegers O, Minon JM, et al. Newborn screening for sickle cell disease using tandem mass spectrometry. Clin Chem. 2008;54(12):2036–2041. DOI:https://doi.org/10.1373/clinchem.2008.106369.
   PubMed Web of Science ®Google Scholar
• Kasai E, Boemer F, Djang’eing’a R, et al. Systematic screening of neonatal sickle cell disease with HemoTypeSCTM Kit-test: case study and literature review. Open J Blood Dis. 2020;10:12–21. DOI:https://doi.org/10.4236/ojbd.2020.101002.
   Google Scholar
• Segbena AY, Guindo A, Buono R, et al. Diagnostic accuracy in field conditions of the sickle SCAN® rapid test for sickle cell disease among children and adults in two West African settings: the DREPATEST study. BMC Hematol. 2018;18:26, DOI:https://doi.org/10.1186/s12878-018-0120-5.
   PubMedGoogle Scholar
• Aloni MN, Nkee L. Challenge of managing sickle cell disease in a pediatric population living in Kinshasa, democratic Republic of Congo: a sickle cell center experience. Hemoglobin. 2014;38(3):196–200. DOI:https://doi.org/10.3109/03630269.2014.896810.
   PubMed Web of Science ®Google Scholar
• Lowenthal EA, Mayo MS, Cornwell PE, et al. Homocysteine elevation in sickle cell disease. J Am Coll Nutr. 2000;19(5):608–612. DOI:https://doi.org/10.1080/07315724.2000.10718958.
   PubMed Web of Science ®Google Scholar
• Liu YK. Folic acid deficiency in sickle cell anaemia. Scand J Haematol. 1975;14(1):71–79. DOI:https://doi.org/10.1111/j.1600-0609.1975.tb00295.x.
   PubMedGoogle Scholar
• Al-Yassin A, Osei A, Rees D. Folic acid supplementation in children with sickle cell disease. Arch Dis Child. 2012;97:A91–A92. DOI:https://doi.org/10.1136/archdischild-2012-301885.219.
   PubMed Web of Science ®Google Scholar
• Ofakunrin AOD, Oguche S, Adekola K, et al. Effectiveness and safety of hydroxyurea in the treatment of sickle cell anaemia children in Jos, North Central Nigeria. J Trop Pediatr. 2020;66(3):290–298. DOI:https://doi.org/10.1093/tropej/fmz070.
   PubMed Web of Science ®Google Scholar
• Thornburg CD, Files BA, Luo Z, et al. Impact of hydroxyurea on clinical events in the BABY HUG trial. Blood. 2012;120(22):4304–4310. DOI:https://doi.org/10.1182/blood-2012-03-419879.
   PubMed Web of Science ®Google Scholar
• Brecher ME. American Association of Blood Banks. Technical manual. 14th ed., Bethesda (MA): Brecher ME; 2002.
   Google Scholar
• Batina-Agasa S, Kambale-Kombi P, Kabamba P, et al. Sickle cell trait among blood donors in the Democratic Republic of the Congo: which transfusion policy for sickle cell patients? ISBT ScSer. 2020;1–4. DOI:https://doi.org/10.1111/voxs.12580
   Google Scholar
• Batina A, Kabemba S, Malengela R. Marqueurs infectieux chez les donneurs de sang en République Démocratique du Congo (RDC) [Infectious markers among blood donors in Democratic Republic of Congo (DRC)]. Rev Med Brux. 2007;28(3):145–149.
   PubMedGoogle Scholar
• Mukendi PC, Katala MK, Ndala DB, et al. Seroprevalence of Hepatitis B among blood donors in Mbuji-Mayi, “Case of Dipumba General Hospital” (DRC). Open Access Library Journal. 2017;2017(04):1–7. DOI:https://doi.org/10.4236/oalib.1103503.
   Google Scholar
• Treleaven J, Gennery A, Marsh J, et al. Guidelines on the use of irradiated blood components prepared by the British Committee for Standards in Haematology blood transfusion task force. Br J Haematol. 2011;152(1):35–51. DOI:https://doi.org/10.1111/j.1365-2141.2010.08444.x.
   PubMed Web of Science ®Google Scholar
• CDC. 2018. Vaccine recommendations for patients with sickle cell disease (includes Hgb SS, Hgb SC, Hgb SB null and Hgb SB minor). [cited 2020 May 30]. Available from: https://missionhealth.org/wp-content/uploads/2018/04/CDC-Vaccine-Recommendations-for-Patients-with-Sickle-Cell-Disease.pdf.
   Google Scholar
• Galadanci N, Wudil BJ, Balogun TM, et al. Current sickle cell disease management practices in Nigeria. Int Health. 2014;6(1):23–28. DOI:https://doi.org/10.1093/inthealth/iht022.
   PubMed Web of Science ®Google Scholar
• Rankine-Mullings AE, Owusu-Ofori S. Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. Cochrane Database Syst Rev. 2017;10(10). CD003427. DOI:https://doi.org/10.1002/14651858.CD003427.pub4.
   Google Scholar
• Yee ME, Bakshi N, Graciaa SH, et al. Incidence of invasive Haemophilus influenzae infections in children with sickle cell disease. Pediatr Blood Cancer. 2019;66(6):e27642. DOI:https://doi.org/10.1002/pbc.27642.
   PubMed Web of Science ®Google Scholar
• Taylor SM, Messina JP, Hand CC, et al. Molecular malaria epidemiology: mapping and burden estimates for the Democratic Republic of the Congo, 2007. PLoS One. 2011;6(1):e16420. DOI:https://doi.org/10.1371/journal.pone.0016420.
   PubMed Web of Science ®Google Scholar
• Frimpong A, Thiam LG, Arko-Boham B, et al. Safety and effectiveness of antimalarial therapy in sickle cell disease: a systematic review and network meta-analysis. BMC Infect Dis. 2018;18(1):650, Published 2018 Dec 12. DOI:https://doi.org/10.1186/s12879-018-3556-0.
   PubMedGoogle Scholar